Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsGlenmarkpharma

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Buy Glenmark Pharma, says Sudarshan Sukhani

      One can buy Glenmark Pharma, says Sudarshan Sukhani of s2analytics.com.

    • Delhi HC verdict on Januvia boost for Glenmark: Antique

      In an interview to CNBC-TV18 pharma analyst, Anmol Ganjoo of Antique Stock Broking said Delhi High court's verdict on Januvia Generic will be a positive for Glenmark Pharma.

    • Check out: Trading picks from market experts

      In an interview to CNBC-TV18, Sudarshan Sukhani of s2analytics.com, SP Tulsian of sptulsian.com and Vishal Kshatriya, Edelweiss give top pick for the day.

    • Prefer Glenmark, Ipca Labs, says PN Vijay

      One can prefer Glenmark Pharma and Ipca Labs, says PN Vijay, Portfolio Manager.

    • See lot of speculative upside in ADAG stocks: PN Vijay

      In an interview to CNBC-TV18, portfolio manager PN Vijay spoke about various stocks, sector and all that is making news in the market right now.

    • Prefer Glenmark Pharma, Biocon over Divis Lab: SP Tulsian

      SP Tulsian, sptulsian.com advises to prefer Glenmark Pharma and Biocon over Divis Lab.

    • Glenmark Pharma can move upto Rs 540-550, says PN Vijay

      Glenmark Pharma can move upto Rs 540-550 in next two-three months, says PN Vijay, Portfolio Manager.

    • Go long in Glenmark, target of Rs 540: Jai Bala

      Jai Bala of cashthechaos.com advised taking long positions in Glenmark Pharma. He expects a target of Rs 540 on the stock.

    • SP Tulsian upbeat on Glenmark Pharma, Wockhardt

      SP Tulsian of sptulsian.com is upbeat on Glenmark Pharma, Wockhardt and Lupin.

    • Cash flow improvement may lead to Glenmark re-rating: IIFL

      Cash flow improvement may lead to Glenmark re-rating, says Bino Pathiparampil, IIFL Institutional Equities.

    • See 20% annual returns from Sun Pharma: IIFL Instl Eq

      According to pharma analyst Bino Pathiparampil of IIFL Institutional Equities Sun Pharma could make USD 100 million from Doxil.

    • Buy Glenmark Pharma, Ipca Labs: Diwan

      Prakash Diwan, Prakash Diwan's Wealth Circle is of the view that Glenmark Pharma, Ipca Laboratories both stocks offer very good entry at the current levels.

    • Buy Dhanlaxmi Bank, Glenmark Pharma, SpiceJet: Parag Doctor

      In CNBC-TV18's popular show Bull's Eye, Parag Doctor, Keynote Capital shares trading strategy of the day.

    • Bull's eye: Buy Unitech, IRB Infra; short HDIL, OBC

      Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

    • Drugs that give Morgan high: Sun, Reddy's, Lupin, Glenmark

      Brokerage house Morgan Stanley has rated Dr Reddy‘s, Sun Pharma, Lupin and Glenmark as its top picks in the pharmaceuticals sector.

    • Glenmark Pharma can move to Rs 570: Jai Bala

      In Glenmark Pharma one can place a stoploss below Rs 510 and expect the stock to touch about Rs 570 odds, says Jai Bala, cashthechaos.com.

    • Buy Arvind, HDIL, Sun TV: Parag Doctor

      In CNBC-TV18's popular show Bull's Eye, Parag Doctor of Keynote Capital shares trading strategy of the day.

    • Glenmark Pharma has target of Rs 575-580: Sukhani

      Glenmark Pharma has target of Rs 575-580, says Sudarshan Sukhani of s2analytics.com.

    • Bull's Eye: Buy Sun TV, Fortis, Zee Learn, L&T Finance

      Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

    • Buy Glenmark Pharma at Rs 510, says Kulkarni

      Shardul Kulkarni of Angel Broking is of the view that, good strong move is expected in Glenmark Pharma in the near term, so one can look at buying opportunity in the stock at Rs 510 or on declines.

    • Prefer Glenmark Pharma: Sudarshan Sukhani

      Prefer Glenmark Pharma, says Sudarshan Sukhani, s2analytics.com.

    • Buy Amtek Auto, Glenmark Pharma, sell HDIL: Parag Doctor

      In CNBC-TV18's popular show Bull's Eye, Parag Doctor of Keynote Capital shares trading strategy of the day.

    • Sun Pharmaceuticals, Lupin top picks: Mehraboon Irani

      Sun Pharmaceuticals and Lupin are top picks, says Mehraboon Irani, Nirmal Bang Securities.

    • Bull's eye: Short Rel Power, United Spirits; buy Glenmark

      Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

    • Fantastic 4: Stocks that can fetch good returns in a week

      In an interview to CNBC-TV18, SP Tulsian of sptulsian.com shared his views on stocks across various sectors. He picked four multibagger stocks for the week ahead. He suggested going long on Pantaloon, Century Textiles, Tata Global and Wockhardt.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347